Loss-of-Function Variants in Schizophrenia Risk and SETD1A as a Candidate Susceptibility Gene

Neuron

Volumn 82, Issue 4, 2014, Pages 773-780

  Takata, Atsushi ^a   Xu, Bin ^a   Ionita Laza, Iuliana ^a   Roos, J Louw ^b   Gogos, Joseph A ^a   Karayiorgou, Maria ^a,c  

^a NewYork Presbyterian Hospital   (United States)

^b UNIVERSITY OF PRETORIA   (South Africa)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; EXOME; FRAMESHIFT MUTATION; GENE; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; INDEL MUTATION; LOSS OF FUNCTION MUTATION; MAJOR CLINICAL STUDY; NONSENSE MUTATION; PRIORITY JOURNAL; SCHIZOPHRENIA; SETD1A GENE;

CHROMATIN ASSEMBLY AND DISASSEMBLY; COHORT STUDIES; FEMALE; GENE FREQUENCY; GENE REGULATORY NETWORKS; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME, HUMAN; GENOTYPE; HISTONE-LYSINE N-METHYLTRANSFERASE; HUMANS; LIKELIHOOD FUNCTIONS; MALE; RISK FACTORS; SCHIZOPHRENIA; SEQUENCE ANALYSIS, DNA;

EID: 84900986803     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2014.04.043     Document Type: Article

References (62)

1. Abecasis G.R., Auton A., Brooks L.D., DePristo M.A., Durbin R.M., Handsaker R.E., Kang H.M., Marth G.T., McVean G.A. An integrated map of genetic variation from 1,092 human genomes. Nature 2012, 491:56-65. 1000 Genomes Project Consortium.
2. Adzhubei I.A., Schmidt S., Peshkin L., Ramensky V.E., Gerasimova A., Bork P., Kondrashov A.S., Sunyaev S.R. A method and server for predicting damaging missense mutations. Nat. Methods 2010, 7:248-249.
3. Albers C.A., Lunter G., MacArthur D.G., McVean G., Ouwehand W.H., Durbin R. Dindel: accurate indel calls from short-read data. Genome Res. 2011, 21:961-973.
4. Ben-David E., Shifman S. Combined analysis of exome sequencing points toward a major role for transcription regulation during brain development in autism. Mol. Psychiatry 2013, 18:1054-1056.
5. Bottas A., Cooke R.G., Richter M.A. Comorbidity and pathophysiology of obsessive-compulsive disorder in schizophrenia: is there evidence for a schizo-obsessive subtype of schizophrenia?. J.Psychiatry Neurosci. 2005, 30:187-193.
6. Cingolani P., Platts A., Wang L., Coon M., Nguyen T., Wang L., Land S.J., Lu X., Ruden D.M. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly (Austin) 2012, 6:80-92.
7. Crow J.F. The origins, patterns and implications of human spontaneous mutation. Nat. Rev. Genet. 2000, 1:40-47.
8. de Ligt J., Willemsen M.H., van Bon B.W., Kleefstra T., Yntema H.G., Kroes T., Vulto-van Silfhout A.T., Koolen D.A., de Vries P., Gilissen C., et al. Diagnostic exome sequencing in persons with severe intellectual disability. N.Engl. J. Med. 2012, 367:1921-1929.
9. Dehé P.M., Dichtl B., Schaft D., Roguev A., Pamblanco M., Lebrun R., Rodríguez-Gil A., Mkandawire M., Landsberg K., Shevchenko A., et al. Protein interactions within the Set1 complex and their roles in the regulation of histone 3 lysine 4 methylation. J.Biol. Chem. 2006, 281:35404-35412.
10. Edmonds D.K., Lindsay K.S., Miller J.F., Williamson E., Wood P.J. Early embryonic mortality in women. Fertil. Steril. 1982, 38:447-453.
11. Gilman S.R., Chang J., Xu B., Bawa T.S., Gogos J.A., Karayiorgou M., Vitkup D. Diverse types of genetic variation converge on functional gene networks involved in schizophrenia. Nat. Neurosci. 2012, 15:1723-1728.
12. Girard S.L., Gauthier J., Noreau A., Xiong L., Zhou S., Jouan L., Dionne-Laporte A., Spiegelman D., Henrion E., Diallo O., et al. Increased exonic de novo mutation rate in individuals with schizophrenia. Nat. Genet. 2011, 43:860-863.
13. Goriely A., McGrath J.J., Hultman C.M., Wilkie A.O., Malaspina D. "Selfish spermatogonial selection": a novel mechanism for the association between advanced paternal age and neurodevelopmental disorders. Am. J. Psychiatry 2013, 170:599-608.
14. Gulsuner S., Walsh T., Watts A.C., Lee M.K., Thornton A.M., Casadei S., Rippey C., Shahin H., Nimgaonkar V.L., Go R.C., et al. Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network. Cell 2013, 154:518-529. Consortium on the Genetics of Schizophrenia (COGS), PAARTNERS Study GroupPAARTNERS Study Group.
15. Gupta S., Kim S.Y., Artis S., Molfese D.L., Schumacher A., Sweatt J.D., Paylor R.E., Lubin F.D. Histone methylation regulates memory formation. J.Neurosci. 2010, 30:3589-3599.
16. He X., Sanders S.J., Liu L., De Rubeis S., Lim E.T., Sutcliffe J.S., Schellenberg G.D., Gibbs R.A., Daly M.J., Buxbaum J.D., et al. Integrated model of de novo and inherited genetic variants yields greater power to identify risk genes. PLoS Genet. 2013, 9:e1003671.
17. Hu X., Zhang B., Liu W., Paciga S., He W., Lanz T.A., Kleiman R., Dougherty B., Hall S.K., McIntosh A.M., et al. A survey of rare coding variants in candidate genes in schizophrenia by deep sequencing. Mol. Psychiatry 2013, Published online October 15, 2013. 10.1038/mp.2013.131.
18. Huang H.S., Matevossian A., Whittle C., Kim S.Y., Schumacher A., Baker S.P., Akbarian S. Prefrontal dysfunction in schizophrenia involves mixed-lineage leukemia 1-regulated histone methylation at GABAergic gene promoters. J.Neurosci. 2007, 27:11254-11262.
19. Huang W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4:44-57.
20. Ionita-Laza I., Xu B., Makarov V., Buxbaum J.D., Roos J.L., Gogos J.A., Karayiorgou M. Scan statistic-based analysis of exome sequencing data identifies FAN1 at 15q13.3 as a susceptibility gene for schizophrenia and autism. Proc. Natl. Acad. Sci. USA 2014, 111:343-348.
21. Iossifov I., Ronemus M., Levy D., Wang Z., Hakker I., Rosenbaum J., Yamrom B., Lee Y.H., Narzisi G., Leotta A., et al. De novo gene disruptions in children on the autistic spectrum. Neuron 2012, 74:285-299.
22. Jensen L.R., Amende M., Gurok U., Moser B., Gimmel V., Tzschach A., Janecke A.R., Tariverdian G., Chelly J., Fryns J.P., et al. Mutations in the JARID1C gene, which is involved in transcriptional regulation and chromatin remodeling, cause X-linked mental retardation. Am. J. Hum. Genet. 2005, 76:227-236.
23. Jiang Y., Wang Y., Brudno M. PRISM: pair-read informed split-read mapping for base-pair level detection of insertion, deletion and structural variants. Bioinformatics 2012, 28:2576-2583.
24. Karayiorgou M., Morris M.A., Morrow B., Shprintzen R.J., Goldberg R., Borrow J., Gos A., Nestadt G., Wolyniec P.S., Lasseter V.K., et al. Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc. Natl. Acad. Sci. USA 1995, 92:7612-7616.
25. Karayiorgou M., Flint J., Gogos J.A., Malenka R.C. The best of times, the worst of times for psychiatric disease. Nat. Neurosci. 2012, 15:811-812. Genetic and Neural Complexity in Psychiatry 2011 Working Group.
26. Kenny E.M., Cormican P., Furlong S., Heron E., Kenny G., Fahey C., Kelleher E., Ennis S., Tropea D., Anney R., et al. Excess of rare novel loss-of-function variants in synaptic genes in schizophrenia and autism spectrum disorders. Mol. Psychiatry 2013, Published online October 15, 2013. 10.1038/mp.2013.127.
27. Kirov G., Pocklington A.J., Holmans P., Ivanov D., Ikeda M., Ruderfer D., Moran J., Chambert K., Toncheva D., Georgieva L., et al. De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol. Psychiatry 2012, 17:142-153.
28. Lim E.T., Raychaudhuri S., Sanders S.J., Stevens C., Sabo A., MacArthur D.G., Neale B.M., Kirby A., Ruderfer D.M., Fromer M., et al. Rare complete knockouts in humans: population distribution and significant role in autism spectrum disorders. Neuron 2013, 77:235-242. NHLBI Exome Sequencing Project.
29. MacArthur D.G., Balasubramanian S., Frankish A., Huang N., Morris J., Walter K., Jostins L., Habegger L., Pickrell J.K., Montgomery S.B., et al. A systematic survey of loss-of-function variants in human protein-coding genes. Science 2012, 335:823-828. 1000 Genomes Project Consortium.
30. Malhotra D., Sebat J. CNVs: harbingers of a rare variant revolution in psychiatric genetics. Cell 2012, 148:1223-1241.
31. Malhotra D., McCarthy S., Michaelson J.J., Vacic V., Burdick K.E., Yoon S., Cichon S., Corvin A., Gary S., Gershon E.S., et al. High frequencies of de novo CNVs in bipolar disorder and schizophrenia. Neuron 2011, 72:951-963.
32. McKenna A., Hanna M., Banks E., Sivachenko A., Cibulskis K., Kernytsky A., Garimella K., Altshuler D., Gabriel S., Daly M., DePristo M.A. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010, 20:1297-1303.
33. Merla G., Brunetti-Pierri N., Micale L., Fusco C. Copy number variants at Williams-Beuren syndrome 7q11.23 region. Hum. Genet. 2010, 128:3-26.
34. Miller T., Krogan N.J., Dover J., Erdjument-Bromage H., Tempst P., Johnston M., Greenblatt J.F., Shilatifard A. COMPASS: a complex of proteins associated with a trithorax-related SET domain protein. Proc. Natl. Acad. Sci. USA 2001, 98:12902-12907.
35. Mohan M., Lin C., Guest E., Shilatifard A. Licensed to elongate: a molecular mechanism for MLL-based leukaemogenesis. Nat. Rev. Cancer 2010, 10:721-728.
36. Mukai J., Dhilla A., Drew L.J., Stark K.L., Cao L., MacDermott A.B., Karayiorgou M., Gogos J.A. Palmitoylation-dependent neurodevelopmental deficits in a mouse model of 22q11 microdeletion. Nat. Neurosci. 2008, 11:1302-1310.
37. Nacak T.G., Leptien K., Fellner D., Augustin H.G., Kroll J. The BTB-kelch protein LZTR-1 is a novel Golgi protein that is degraded upon induction of apoptosis. J.Biol. Chem. 2006, 281:5065-5071.
38. Neale B.M., Kou Y., Liu L., Ma'ayan A., Samocha K.E., Sabo A., Lin C.F., Stevens C., Wang L.S., Makarov V., et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 2012, 485:242-245.
39. O'Roak B.J., Vives L., Fu W., Egertson J.D., Stanaway I.B., Phelps I.G., Carvill G., Kumar A., Lee C., Ankenman K., et al. Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. Science 2012, 338:1619-1622.
40. O'Roak B.J., Vives L., Girirajan S., Karakoc E., Krumm N., Coe B.P., Levy R., Ko A., Lee C., Smith J.D., et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 2012, 485:246-250.
41. Otto S.P., Hastings I.M. Mutation and selection within the individual. Genetica 1998, 102-103:507-524.
42. Petrovski S., Wang Q., Heinzen E.L., Allen A.S., Goldstein D.B. Genic intolerance to functional variation and the interpretation of personal genomes. PLoS Genet. 2013, 9:e1003709.
43. Rauch A., Wieczorek D., Graf E., Wieland T., Endele S., Schwarzmayr T., Albrecht B., Bartholdi D., Beygo J., Di Donato N., et al. Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study. Lancet 2012, 380:1674-1682.
44. Ripke S., O'Dushlaine C., Chambert K., Moran J.L., Kähler A.K., Akterin S., Bergen S.E., Collins A.L., Crowley J.J., Fromer M., et al. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat. Genet. 2013, 45:1150-1159. Multicenter Genetic Studies of Schizophrenia Consortium, Psychosis Endophenotypes International ConsortiumPsychosis Endophenotypes International Consortium, Wellcome Trust Case Control Consortium 2Wellcome Trust Case Control Consortium 2.
45. Robinson J.T., Thorvaldsdóttir H., Winckler W., Guttman M., Lander E.S., Getz G., Mesirov J.P. Integrative genomics viewer. Nat. Biotechnol. 2011, 29:24-26.
46. Rodriguez-Murillo L., Gogos J.A., Karayiorgou M. The genetic architecture of schizophrenia: new mutations and emerging paradigms. Annu. Rev. Med. 2012, 63:63-80.
47. Roguev A., Schaft D., Shevchenko A., Pijnappel W.W., Wilm M., Aasland R., Stewart A.F. The Saccharomyces cerevisiae Set1 complex includes an Ash2 homologue and methylates histone 3 lysine 4. EMBO J. 2001, 20:7137-7148.
48. Ronan J.L., Wu W., Crabtree G.R. From neural development to cognition: unexpected roles for chromatin. Nat. Rev. Genet. 2013, 14:347-359.
49. Sanders S.J., Murtha M.T., Gupta A.R., Murdoch J.D., Raubeson M.J., Willsey A.J., Ercan-Sencicek A.G., DiLullo N.M., Parikshak N.N., Stein J.L., et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 2012, 485:237-241.
50. Schlichter A., Cairns B.R. Histone trimethylation by Set1 is coordinated by the RRM, autoinhibitory, and catalytic domains. EMBO J. 2005, 24:1222-1231.
51. Shilatifard A. The COMPASS family of histone H3K4 methylases: mechanisms of regulation in development and disease pathogenesis. Annu. Rev. Biochem. 2012, 81:65-95.
52. Shulha H.P., Cheung I., Guo Y., Akbarian S., Weng Z. Coordinated cell type-specific epigenetic remodeling in prefrontal cortex begins before birth and continues into early adulthood. PLoS Genet. 2013, 9:e1003433.
53. Veltman J.A., Brunner H.G. De novo mutations in human genetic disease. Nat. Rev. Genet. 2012, 13:565-575.
54. Wynder C., Hakimi M.A., Epstein J.A., Shilatifard A., Shiekhattar R. Recruitment of MLL by HMG-domain protein iBRAF promotes neural differentiation. Nat. Cell Biol. 2005, 7:1113-1117.
55. Xu B., Roos J.L., Levy S., van Rensburg E.J., Gogos J.A., Karayiorgou M. Strong association of de novo copy number mutations with sporadic schizophrenia. Nat. Genet. 2008, 40:880-885.
56. Xu B., Roos J.L., Dexheimer P., Boone B., Plummer B., Levy S., Gogos J.A., Karayiorgou M. Exome sequencing supports a de novo mutational paradigm for schizophrenia. Nat. Genet. 2011, 43:864-868.
57. Xu B., Ionita-Laza I., Roos J.L., Boone B., Woodrick S., Sun Y., Levy S., Gogos J.A., Karayiorgou M. De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia. Nat. Genet. 2012, 44:1365-1369.
58. Xu B., Hsu P.K., Stark K.L., Karayiorgou M., Gogos J.A. Derepression of a neuronal inhibitor due to miRNA dysregulation in a schizophrenia-related microdeletion. Cell 2013, 152:262-275.
59. Yates J.A., Menon T., Thompson B.A., Bochar D.A. Regulation of HOXA2 gene expression by the ATP-dependent chromatin remodeling enzyme CHD8. FEBS Lett. 2010, 584:689-693.
60. Ye K., Schulz M.H., Long Q., Apweiler R., Ning Z. Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads. Bioinformatics 2009, 25:2865-2871.
61. Yu T.W., Chahrour M.H., Coulter M.E., Jiralerspong S., Okamura-Ikeda K., Ataman B., Schmitz-Abe K., Harmin D.A., Adli M., Malik A.N., et al. Using whole-exome sequencing to identify inherited causes of autism. Neuron 2013, 77:259-273.
62. Zhu Q., Ge D., Maia J.M., Zhu M., Petrovski S., Dickson S.P., Heinzen E.L., Shianna K.V., Goldstein D.B. A genome-wide comparison of the functional properties of rare and common genetic variants in humans. Am. J. Hum. Genet. 2011, 88:458-468.